-
-
-
-
-
-
-
VistaGen Therapeutics (VTGN) call put ratio 1 call to 1.1 puts as share price down 80%
-
-
-
-
-
-
-
Increasing unusual call option volume: AMTM VTGN LEN FIP ROK RPD GNW ZM SMTC METU EAT ALHC
-
-
-
-
-
-
-
VistaGen Therapeutics (VTGN) Receives U.S. Patent for AV-101 to Treat Neuropathic Pain
-
-
-
484,013 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


